Top Feature

Jan 12, 2018
Pharmaceutical Executive
In our annual temperature check on the life sciences sector and its outlook for the months ahead, we explore eight trends that will shape the biopharma industry landscape in 2018.
Jan 12, 2018
Pharmaceutical Executive
Bruno Strigini, CEO of Novartis Oncology, talks about the company’s pioneering path in cancer and the related broader issues such as pricing and value and new innovations in cancer science.
Dec 30, 2017
Pharmaceutical Executive
Pharm Exec details the latest approaches to combating disease and health crises on a global scale—including industry perspectives from those involved on the front lines.
Dec 11, 2017
Pharmaceutical Executive
Groundbreaking treatment approaches call for innovative commercialization strategies.
Dec 10, 2017
Pharmaceutical Executive
By
How Ruud Dobber is steering AstraZeneca’s US course as it navigates the complexities of a fast-evolving therapeutic market.
Nov 30, 2017
Mark Bouch, Stephen Bungay, and David Roblin outline how the technique of "mission command", a military approach to setting direction and executing strategy in the pharmaceutical industry, has developed over the last ten years.
Nov 30, 2017
Pharmaceutical Executive
Analysis shows that persistence is paying off for drug developers, driven by the rise of CAR-T and other gene therapy, newly discovered cancer targets, better patient identification methods.
Nov 13, 2017
Pharmaceutical Executive
With its convergence of healthcare talent and tech, the nation is turning into a prime destination for innovative startups.
Oct 31, 2017
Ed Gudaitis Allergan VP and Country Manager, Canada, explains how embracing disruption is his secret to success.
Oct 31, 2017
Pharmaceutical Executive
Pharm Exec’s 10th annual list of rising leaders highlights 11 pharma managers who are poised to help chart the industry’s path forward.
native1_300x100
on-line levitra

danabol-in.com/injection/trenbolon/trenbolone_acetat_sp_laboratories

buysteroids.in.ua/kupit-zhiroszhigateli/clenodyn.html
lorem ipsum